Open AccessMyeloma
Author(s) -
Mark Fuerst
Publication year - 2014
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000450343.80993.28
Subject(s) - pomalidomide , lenalidomide , bortezomib , medicine , multiple myeloma , carfilzomib , oncology , combination therapy , refractory (planetary science) , dexamethasone , thalidomide , biology , astrobiology